The mechanism of action by inhibiting the JAK1 pathway modulates multiple cytokines involved in the pathophysiology of AD, including IL-4, IL-13, IL-31, IL-22, and IFN-γ and TSLP.91, 105. Here, IL31 is linked to Alzheimer disease.